23andMe expands collaboration with Genentech

01/31/2013 | GenomeWeb Daily News (free registration)

23andMe is asking for saliva samples from any U.S. patient who used Avastin before this year to treat certain metastatic cancers. Study participants will be asked to send a saliva sample and may also submit a blood sample for genetic analysis, and will complete five online surveys throughout the year. The study, called InVite, aims to identify new genetic markers for the diseases and to understand differences in patient response.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC